Kolexia
Bassez Clemence Cardiologie
Bassez Clemence
Cardiologie
Centre Hospitalier Toulon
Toulon, France
46 Activités
48 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome coronarien aigu Hémorragie Insuffisance rénale chronique Choc cardiogénique Défaillance cardiaque Choc Hypoxie Polyglobulie primitive essentielle Ischémie myocardique

Collaborateurs

Voir plus
Quaino Gonzalo
Quaino Gonzalo
Centre Hospitalier Toulon, Toulon, France
Benzakin Frederic
Benzakin Frederic
Centre Hospitalier Toulon, Toulon, France
Tartiere Jean-Michel
Tartiere Jean-Michel
Centre Hospitalier Toulon, Toulon, France
Bonnet Jean Louis
Bonnet Jean Louis
Clinique Bonneveine, Marseille, France

Industries

Voir plus
Boston Scientific
9 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023
Amgen
2 collaboration(s)
Dernière en 2023
Bayer
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity: The TOPIC-VASP Pre-Specified Analysis of the TOPIC Randomized Study.
JACC. Cardiovascular interventions   09 avril 2019
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.
European heart journal   09 juillet 2018
Impact of diabetes on benefit of switching dual antiplatelet therapy after acute coronary syndrome: A subanalysis of the TOPIC randomized study
Archives of Cardiovascular Diseases Supplements   01 janvier 2018
Benefit of switching dual antiplatelet therapy after ACS according to platelet reactivity: A prespecified analysis of the TOPIC randomized study
Archives of Cardiovascular Diseases Supplements   01 janvier 2018
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: The TOPIC (Timing Of Platelet Inhibition after acute Coronary Syndrome) randomized study
Archives of Cardiovascular Diseases Supplements   01 janvier 2018
Benefit of switching dual antiplatelet therapy after ACS on dual antiplatelet therapy adherence: A prespecified analysis of the TOPIC randomized study
Archives of Cardiovascular Diseases Supplements   01 janvier 2018
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.
International journal of cardiology   24 février 2015
Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel.
International journal of cardiology   05 août 2014
Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome.
International journal of cardiology   04 août 2014
Ischemic heart failure making the diagnosis of a Vaquez disease: a rare event.
Annales francaises d'anesthesie et de reanimation   18 juin 2014